The following is from the IPT September quarterly and shows the IPT, MAG, ALK and AQX tenements around Boda. Again it is hard to precisely tell, but the historical Jawbone site from the post by apsludh would appeat to be close to teh border of MAG and IPT tenements.
http://www.aspecthuntley.com.au/docserver/02301331.pdf?fileid=02301331&datedir=20201029&edt=MjAyMC0xMS0xMSsxNToyNToxMSs0ODArMTAxNTcxMSthbmRyZXd3ZXN0K3JlZGlyZWN0K2h0dHA6Ly93d3cuYXNwZWN0aHVudGxleS5jb20uYXUvaW1hZ2VzaWduYWwvZXJyb3JwYWdlcy9wZGZ0aW1lb3V0Lmh0bWwraHR0cDovL3d3dy5hc3BlY3RodW50bGV5LmNvbS5hdS9pbWFnZXNpZ25hbC9lcnJvcnBhZ2VzL3BkZmRlbGF5ZWQuanNw
- Forums
- ASX - By Stock
- ALK
- Ann: Significant Expansion to Mineralisation at Boda
Ann: Significant Expansion to Mineralisation at Boda, page-145
-
-
- There are more pages in this discussion • 136 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
Add ALK (ASX) to my watchlist
|
|||||
Last
55.0¢ |
Change
0.020(3.77%) |
Mkt cap ! $331.9M |
Open | High | Low | Value | Volume |
53.5¢ | 55.5¢ | 53.5¢ | $668.4K | 1.220M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 100906 | 55.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
55.5¢ | 117919 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 100906 | 0.550 |
2 | 8964 | 0.545 |
8 | 165910 | 0.540 |
1 | 6000 | 0.535 |
9 | 89550 | 0.530 |
Price($) | Vol. | No. |
---|---|---|
0.555 | 117919 | 5 |
0.560 | 10856 | 2 |
0.565 | 46659 | 4 |
0.570 | 39000 | 3 |
0.575 | 77000 | 2 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
ALK (ASX) Chart |